Relationship between vitamin D status and incidence of vascular events in the veterans affairs diabetes trial

Atherosclerosis

Volumn 228, Issue 2, 2013, Pages 502-507

  Alele, Jimmy D ^a   Luttrell, Louis M ^a,b   Hollis, Bruce W ^a   Luttrell, Deirdre K ^a   Hunt, Kelly J ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Cardiovascular outcomes; Diabetes mellitus; Epidemiology; Prospective cohort study; Vitamin D

Indexed keywords

VITAMIN D;

ADULT; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC KIDNEY DISEASE; CONGESTIVE HEART FAILURE; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; TRANSIENT ISCHEMIC ATTACK; VITAMIN BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84878107314     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.03.024     Document Type: Article

References (35)

1. 2 vitamin D3 receptors and actions in vascular smooth muscle cells invitro. Calcif Tissue Int 1987, 41(2):112-114.
2. Merke J., Milde P., Lewicka S., et al. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. JClin Invest 1989, 83(6):1903-1915.
3. Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006, 81(3):353-373.
4. Zehnder D., Bland R., Chana R.S., et al. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. JAm Soc Nephrol 2002, 13(3):621-629.
5. Somjen D., Weisman Y., Kohen F., et al. 25-hydroxyvitamin D3-1alpha-hydroxylase is expressed in human vascular smooth muscle cells and is upregulated by parathyroid hormone and estrogenic compounds. Circulation 2005, 111(13):1666-1671.
6. Lind L., Hanni A., Lithell H., Hvarfner A., Sorensen O.H., Ljunghall S. Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 1995, 8(9):894-901.
7. Fleck A. Latitude and ischaemic heart disease. Lancet 1989, 1(8638):613.
8. Rostand S.G. Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension 1997, 30(2 Pt 1):150-156.
9. Watson K.E., Abrolat M.L., Malone L.L., et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997, 96(6):1755-1760.
10. Scragg R., Jackson R., Holdaway I.M., Lim T., Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 1990, 19(3):559-563.
11. Pilz S., Dobnig H., Nijpels G., et al. Vitamin D and mortality in older men and women. Clin Endocrinol (Oxf) 2009, 71(5):666-672.
12. Ginde A.A., Scragg R., Schwartz R.S., Camargo C.A. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. JAm Geriatr Soc 2009, 57(9):1595-1603.
13. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes. NEngl J Med 2009, 360(2):129-139.
14. Abraira C., Duckworth W., McCarren M., et al. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: veterans affairs diabetes trial. JDiabetes Complications 2003, 17(6):314-322.
15. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2002, 25(1):213-229.
16. Lopes-Virella M.F., Hunt K.J., Baker N.L., Virella G., Moritz T. The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study. Atherosclerosis 2012, 224(2):526-531.
17. Hollis B.W. Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers. Methods Enzymol 1997, 282:174-186.
18. Holick M.F. Vitamin D deficiency. NEngl J Med 2007, 357(3):266-281.
19. Kendrick J., Targher G., Smits G., Chonchol M. 25-Hydroxyvitamin D deficiency is independently associated with cardiovascular disease in the Third National Health and Nutrition Examination Survey. Atherosclerosis 2009, 205(1):255-260.
20. Chapuy M.C., Preziosi P., Maamer M., et al. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos Int 1997, 7(5):439-443.
21. Saha H. Calcium and vitamin D homeostasis in patients with heavy proteinuria. Clin Nephrol 1994, 41(5):290-296.
22. Willerson J.T., Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 2004, 109(21 Suppl. 1):II 2-II 10.
23. Lefer D.J. Statins as potent antiinflammatory drugs. Circulation 2002, 106(16):2041-2042.
24. Perez-Castrillon J.L., Vega G., Abad L., et al. Effects of Atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol 2007, 99(7):903-905.
25. Pittas A.G., Chung M., Trikalinos T., et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann Intern Med 2010, 152(5):307-314.
26. Wang L., Manson J.E., Song Y., Sesso H.D. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med 2010, 152(5):315-323.
27. Zittermann A., Schleithoff S.S., Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br J Nutr 2005, 94(4):483-492.
28. Poole K.E., Loveridge N., Barker P.J., et al. Reduced vitamin D in acute stroke. Stroke 2006, 37(1):243-245.
29. Zittermann A., Schleithoff S.S., Tenderich G., Berthold H.K., Korfer R., Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?. JAm Coll Cardiol 2003, 41(1):105-112.
30. Hintzpeter B., Mensink G.B., Thierfelder W., Muller M.J., Scheidt-Nave C. Vitamin D status and health correlates among German adults. Eur J Clin Nutr 2008, 62(9):1079-1089.
31. Wang T.J., Pencina M.J., Booth S.L., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117(4):503-511.
32. Giovannucci E., Liu Y., Hollis B.W., Rimm E.B. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008, 168(11):1174-1180.
33. de Boer I.H., Sachs M.C., Cleary P.A., et al. Circulating vitamin D metabolites and kidney disease in type 1 diabetes. JClin Endocrinol Metab 2012, 97(12):4780-4788.
34. Bittner V., Wenger N.K., Waters D.D., DeMicco D.A., Messig M., LaRosa J.C. Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease. Am Heart J 2012, 164(3):387-393.
35. Yiu Y.F., Yiu K.H., Siu C.W., et al. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 2013, 227(1):140-146.